Aurobindo Pharma Limited (NSE:AUROPHARMA)
India
· Delayed Price · Currency is INR 1,087.00
-3.00 (-0.28%)
Sep 29, 2025, 3:30 PM IST
Aurobindo Pharma Employees
Aurobindo Pharma had 27,707 employees as of March 31, 2025. The number of employees increased by 1,692 or 6.50% compared to the previous year.
Employees
27,707
Change (1Y)
1,692
Growth (1Y)
6.50%
Revenue / Employee
11.56M INR
Profits / Employee
1.22M INR
Market Cap
633.07B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 27,707 | 1,692 | 6.50% |
| Mar 31, 2024 | 26,015 | 2,564 | 10.93% |
| Mar 31, 2023 | 23,451 | 8,020 | 51.97% |
| Mar 31, 2022 | 15,431 | -3,933 | -20.31% |
| Mar 31, 2021 | 19,364 | 895 | 4.85% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sun Pharmaceutical Industries | 43,000 |
| Divi's Laboratories | 10,542 |
| Cipla | 30,313 |
| Apollo Hospitals Enterprise | 42,497 |
| Mankind Pharma | 26,978 |
| Zydus Lifesciences | 27,917 |
| Fortis Healthcare | 12,237 |
| Alkem Laboratories | 18,785 |
Aurobindo Pharma News
- 10 days ago - Aurobindo Pharma reports fire incident at its Andhra Pradesh unit - Business Upturn
- 10 days ago - Aurobindo Pharma’s CuraTeQ Biologics successfully completes Phase 3 study for denosumab biosimilar - Business Upturn
- 11 days ago - Top stocks to watch today, September 18: TVS Motor, Biocon, Aurobindo Pharma, Bandhan Bank, Federal Bank and more - Business Upturn
- 18 days ago - Why are Aurobindo Pharma shares up 5% today? Know More - Business Upturn
- 21 days ago - Top stocks to watch today, September 8: BHEL, NTPC Green, Adani Green, Aurobindo Pharma and more - Business Upturn
- 23 days ago - Aurobindo Pharma’s Unit-XII receives US FDA Form 483 with 8 observations - Business Upturn
- 4 weeks ago - Aurobindo Pharma’s CuraTeQ Biologics secures UK MHRA approval for biosimilar Dazublys - Business Upturn
- 5 weeks ago - Aurobindo Pharma denies media reports on $5.5 billion Zentiva buyout - Business Upturn